Search results
Results from the WOW.Com Content Network
Supporters of direct-to-consumer advertising argue that advertisements increase competition which leads to lower prescription drug prices and new development, citing, for instance, that between 1997 and 2001, spending on research and development in the U.S. increased 59% while spending on promoting drugs directly to patients increased 145%.
Prescription drug prices have become a key target of criticism by those calling for reforms to the U.S. health care system. Upon taking office, President Biden vowed to lower these prices.
When there is a shortage of FDA-approved, brand-name medication – like with GLP-1 drugs Ozempic and Wegovy – the FDA says it allows compounding pharmacies to make alternative medications that ...
For premium support please call: 800-290-4726 more ways to reach us
The United States federal government is aggressively pursuing criminal and civil cases against pharmaceutical companies and their employees for promoting off-label uses of prescription drugs. [4] Between 2003 and 2008, U.S. federal prosecutors and state attorneys general brought more than a dozen cases against drug manufacturers for off-label ...
Opponents of the controversial nonprofit drafted Prop. 34 to ensure AHF spends the bulk of its funding from a federal drug discount program on patient care, rather than ballot campaigns.
The Elijah Cummings Lower Drug Costs Now Act is proposed legislation in the 117th United States Congress. The bill is designed to lower prescription drug costs in the United States. Notably, the law gives the federal government the power to negotiate prescription drug prices. [1]
In weekly prescription data ending Oct. 18, Eli Lilly's Mounjaro captured 33% of market share, or a year-over-year jump of 79%, while Novo's Ozempic was at 47%, or a year-over-year jump of 39%.